May 06, 2021 8:00am EDT Medolife Rx Implements Proprietary Electro Solution, Further Increasing Efficacy of Polarization Technology
May 04, 2021 8:00am EDT Medolife Rx Announces Historic Product Registration in Dominican Republic Enabling Escozine to Be Sold Throughout Latin America as Natural Alternative Cancer Medicine
Apr 29, 2021 8:00am EDT Medolife Rx Breaks Ground on Lab Facility and Increases Scorpion Count at First-of-Its-Kind Reservation in the Dominican Republic
Apr 20, 2021 8:00am EDT Medolife Rx Announces Pre-Clinical Results on Escozine Showing Synergistic Effect in Killing Cancer Cells When Combined With Chemotherapy Agents
Apr 19, 2021 11:48am EDT Medolife Rx (Quanta, Inc.) Reports Over $1 Million in Revenue in 2020 Year-End Filing, Comments on Operations
Apr 15, 2021 8:30am EDT Medolife Rx to Present at The 2021 Sequire Cannabis Conference on Tuesday, April 20, at 3 p.m. EST/12 p.m. PST
Apr 13, 2021 8:30am EDT Medolife Rx Submits Final Data Set to FDA for IND Filing on Lead Drug Candidate
Apr 08, 2021 8:30am EDT Medolife Rx Announces Positive Pre-Clinical Results Showing Up to 95 Percent Cancer Cell Apoptosis with Introduction of Lead Cancer Drug Candidate
Apr 06, 2021 8:30am EDT Medolife Rx Receives Significant Purchase Order of Immunapen, Its Easy-to-Use Nutraceutical Product Designed to Increase Quality of Life and Support a Healthy Immune System
Apr 01, 2021 9:00am EDT Medolife Rx’s Lead Drug Candidate Escozine® Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic
